Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT

被引:3
|
作者
Geysen, Astrid [1 ]
Goffin, Karolien [1 ,2 ]
Van Weehaeghe, Donatienne [1 ]
Van Laere, Koen [1 ,2 ]
Deroose, Christophe M. [1 ,2 ]
机构
[1] Katholieke Univ Leuven, Univ Hosp Leuven, Nucl Med, Leuven, Belgium
[2] Katholieke Univ Leuven, Dept Imaging & Pathol, Nucl Med & Mol Imaging, Leuven, Belgium
关键词
PSMA; F-18-PSMA-1007; PET/CT; corpus luteum; adenoid cystic tumor; MEMBRANE ANTIGEN; EXPRESSION;
D O I
10.1097/RLU.0000000000004013
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Two women were referred for an F-18-PSMA-1007 PET/CT in follow-up of an adenoid cystic tumor of the subglottic region and the bronchus, respectively. Only limited tracer uptake was seen in the region of local recurrence and in the region of known metastases. Unexpectedly, an incidental finding consisting of a high tracer uptake at a corpus luteum in the ovary was found in both women.
引用
收藏
页码:E331 / E332
页数:2
相关论文
共 50 条
  • [31] Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer
    Panagiotidis, Emmanouil
    Paschali, Anna
    Giannoula, Evanthia
    Chatzipavlidou, Vasiliki
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : E46 - E48
  • [32] 18F-PSMA-1007 Uptake Time: 90 vs 120 mins
    Sanderson, T.
    Stakhiv, O.
    Birchall, J.
    O'Dowd, S.
    O'Connor, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S498 - S498
  • [33] Dual-tracer PET/CT for lung and prostate cancer: 18F-FDG and 18F-PSMA-1007
    Li, Haijun
    Li, Lifeng
    Peng, Dechang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [34] Tubercular Spondylitis A Rare Complication of BCGosis Masquerading as Metastasis on 18F-PSMA-1007 PET/CT
    Bohil, Amit
    Seshadri, Nagabhushan
    Rathi, Nitika
    Fernando, Rashika
    Vinjamuri, Sobhan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : E254 - E256
  • [35] 18F-PSMA-1007 PET/CT Detects Micrometastases in a Patient With Biochemically Recurrent Prostate Cancer
    Giesel, Frederik L.
    Kesch, Claudia
    Yun, Mijin
    Cardinale, Jens
    Haberkorn, Uwe
    Kopka, Klaus
    Kratochwil, Clemens
    Hadaschik, Boris A.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E497 - E499
  • [36] Comparison of PET/CT images with 18F-FDG and 18F-PSMA-1007 in relapsed adenoid cystic carcinoma
    Etchebehere, E.
    Sousa, H. S. V.
    Tobar, N.
    Macedo, L. T.
    Kuba, S.
    Santos, A. O.
    Amorim, B. J.
    Lima, C. S. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S868 - S868
  • [37] 18F-PSMA-1007 multiparametric, dynamic PET/CT in biochemical relapse and progression of prostate cancer
    Sachpekidis, Christos
    Afshar-Oromieh, A.
    Kopka, K.
    Strauss, D. S.
    Pan, L.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 592 - 602
  • [38] Osteonecrosis of the Femoral Head as a Potential Pitfall in 18F-PSMA-1007 PET
    Bailly, Matthieu
    Ibrahim, Nada
    Champeaux-Orange, Elise
    Metrard, Gilles
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 74 - 75
  • [39] Diagnostic value of 18F-PSMA-1007 PET/CT for predicting the pathological grade of prostate cancer
    Niu, Xiao-Bo
    Li, Yan-Peng
    Wang, Jun
    Mei, Xiao-Li
    Zhao, Xue-Yan
    Liu, Ting-Ting
    Xu, Sha-Sha
    Han, Xing-Min
    Cheng, Jing-Liang
    CANCER BIOLOGY & THERAPY, 2024, 25 (01)
  • [40] Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
    Kambiz Rahbar
    Ali Afshar-Oromieh
    Robert Seifert
    Stefan Wagner
    Michael Schäfers
    Martin Bögemann
    Matthias Weckesser
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2055 - 2061